Robin Bruyndonckx

Senior statistician - Head of Statistics as of September 2023

University Name

Belgium

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Epidemiology

50%

Virology

50%

Respiratory Infection

30%

Pharmacoeconomics

30%

Covid-19

30%

Molecular Epidemiology

30%

Cohort Study

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Identificatie van determinanten van antibiotica gebruik en verbetering van voorschrijfgedrag via innovatieve statistische methoden

Open Date: 2018-10-01

Close Date: 2021-09-30

Articles10

Estimated Incidence of Hospitalizations Attributable to RSV Infection Among Adults in Ontario, Canada, Between 2013 and 2019

Article Link

Year:

2024

Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol

Article Link

Year:

2024

Validation of a rapid SARS-CoV-2 antibody test in general practice

Article Link

Year:

2023

Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries

Article Link

Year:

2023

Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study

Article Link

Year:

2023

Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

Article Link

Year:

2022

Nationwide implementation of online communication skills training to reduce overprescribing of antibiotics: a stepped-wedge cluster randomized trial in general practice

Article Link

Year:

2022

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol

Article Link

Year:

2022

Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial

Article Link

Year:

2021

Impact of changing reimbursement criteria on the use of fluoroquinolones in Belgium

Article Link

Year:

2021

Collaborators9

Nele Brusselaers

University of Antwerp

BELGIUM

Samuel Coenen

University of Antwerp

BELGIUM

Slawomir Chlabicz

Medical University of Bialystok

POLAND

Jan Verbakel

University of Oxford

UNITED KINGDOM

Pierre Van Damme

University of Antwerp

BELGIUM

Nick Francis

University of Southampton

UNITED KINGDOM

An De Sutter

BELGIUM

Pär-Daniel Sundvall

MD, PhD, Associate Professor

University of Gothenburg

SWEDEN

Emily Bongard

University of Oxford

UNITED KINGDOM

How do I reach out?

Meet Kite AI